In a groundbreaking longitudinal study published in Pediatric Research, scientists have uncovered complex relationships between serum lipids, adipokines, and the development of obesity and hypertension in children born very preterm. This research probes deeply into the biological underpinnings that link early birth with elevated cardiovascular risks in later childhood and preadolescence, expanding our understanding of how the earliest stages of life might set the stage for chronic health conditions.
Preterm birth, defined as delivery before 37 weeks of gestation, affects approximately one in ten births worldwide and represents a significant public health challenge. Beyond the immediate neonatal complications, preterm infants face a host of long-term health issues. Among these, the propensity for childhood overweight and obesity stands out, not only because of its growing prevalence but also due to its association with increased blood pressure and cardiovascular disease risks in adulthood. However, the biochemical pathways and early biomarkers that link preterm birth with these health outcomes have remained elusive—until now.
The study meticulously followed very-preterm infants through early childhood into preadolescence, tracking their serum concentrations of lipids and adipokines, hormones secreted by adipose tissue that regulate energy balance and inflammation. These biomarkers provide critical insight into metabolic health and dysfunction. Researchers aimed to determine whether variations in these molecules could serve as predictors or correlates of evolving obesity and hypertension in this vulnerable population.
One of the central findings of the study is the dysregulation of specific adipokines in very-preterm infants, which appears to foreshadow the development of overweight or obesity. Adiponectin, a hormone known for its anti-inflammatory properties and insulin-sensitizing effects, was found to be persistently lower in children who later developed elevated systolic blood pressure (SBP). Conversely, leptin levels, which correlate with fat mass and influence appetite regulation, exhibited complex fluctuations during childhood, reflecting the dynamic metabolic changes occurring in these growing individuals.
Equally compelling is the pattern of serum lipid profiles observed. Children born very preterm showed distinct lipidomic signatures compared to term-born peers. Elevated levels of low-density lipoprotein (LDL) cholesterol and triglycerides, coupled with decreased high-density lipoprotein (HDL) cholesterol, were apparent in those predisposed to higher blood pressure and obesity. These alterations in serum lipids suggest a pro-atherogenic lipid milieu developing early in life, potentially accelerating the pathogenesis of cardiovascular disease decades later.
The interplay between adipokine secretion and lipid metabolism could hold the key to understanding the mechanistic pathways driving hypertension and obesity after preterm birth. Chronic low-grade inflammation, endothelial dysfunction, and impaired insulin signaling—processes tightly regulated by adipokines and modified by lipid mediators—might constitute a cascade initiated prematurely due to the stress of early delivery and subsequent neonatal challenges.
This research not only elucidates the biological markers associated with adverse cardiometabolic outcomes but also highlights the critical window of early childhood and preadolescence as a period ripe for intervention. Monitoring serum adipokines and lipid levels could enable healthcare providers to identify at-risk children before overt clinical symptoms emerge, allowing for timely lifestyle modifications or pharmacological approaches.
Importantly, the authors emphasize that while preterm birth predisposes children to these metabolic disturbances, the trajectory is not deterministic. Environmental factors, nutrition, physical activity, and postnatal care practices profoundly influence the degree to which these risks manifest. This underscores the promise of precision medicine strategies tailored to the unique metabolic profiles identified through serum biomarker analyses.
The methodology employed in the study was robust, involving repeated measures of serum lipids and adipokines alongside rigorous assessments of growth parameters and blood pressure readings. Longitudinal data provided a dynamic picture of how these variables evolve over time, influencing each other in complex feedback systems. Such comprehensive data sets are rare, making these findings particularly valuable.
Researchers also discussed the potential for integrating genetic and epigenetic analyses in future studies. Understanding how gene-environment interactions modulate serum biomarker levels and subsequent disease risk could unlock novel preventative and therapeutic targets specific to the preterm population.
Nevertheless, the study acknowledges certain limitations, including the challenges of maintaining cohort retention over multiple years and controlling for confounding variables such as socioeconomic factors and medication use. Despite these hurdles, the strength of the evidence supports the existence of significant links between serum lipids/adipokines and cardiometabolic risk profiles in very-preterm infants.
This work aligns with a growing body of evidence that early-life events—such as preterm birth—have life-altering consequences on metabolic health. Through precise measurement of biochemical markers, clinicians and researchers are better equipped to unravel the complex biological tapestry that begins even before birth but continues to influence health long after infancy.
As childhood obesity and hypertension rates climb globally, the urgent need for early detection and intervention mechanisms becomes increasingly apparent. Studies such as this pave the way for surveillance strategies that could transform pediatric care for high-risk infants, ultimately curtailing the burden of adult cardiovascular diseases rooted in early developmental insults.
The integration of adipokine and lipid profiling into routine pediatric follow-up protocols for preterm infants may revolutionize the way these children’s health trajectories are monitored. Such advancements hold the promise of reducing health disparities attributable to prematurity and ushering in an era of personalized pediatrics based on molecular diagnostics.
In conclusion, the pioneering work by Rosenfeld and colleagues shines a critical light on the biochemical pathways linking very-preterm birth to obesity and hypertension risk. By harnessing the power of longitudinal serum analyses, this study charts a compelling path forward for research and clinical practice aimed at protecting vulnerable children from the cascading effects of early cardiovascular and metabolic dysfunction.
Subject of Research: The relationship between serum lipids, adipokines, and the development of obesity and hypertension in very-preterm infants during early childhood and preadolescence.
Article Title: Relationship between serum lipids/adipokines and obesity/hypertension in very-preterm infants during early childhood and preadolescence.
Article References:
Rosenfeld, C.R., Steven Brown, L., Blanco, V. et al. Relationship between serum lipids/adipokines and obesity/hypertension in very-preterm infants during early childhood and preadolescence. Pediatr Res (2025). https://doi.org/10.1038/s41390-025-04578-w
Image Credits: AI Generated
DOI: 11 December 2025
Tags: adipokines and childhood obesitycardiovascular risks in preterm infantsearly biomarkers of obesityenergy balance and inflammation in childrenhypertension in preadolescentslong-term health issues of preterm infantslongitudinal study on preterm birth effectsmetabolic health in very preterm kidspediatric research on obesitypreterm birth and chronic health conditionspublic health challenges of preterm birthserum lipids and obesity in preterm children
